<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2024-9.2.25</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4747</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Фармацевтическая композиция 1,2,4-триоксоланов с бетулином в рыбьем жире. Влияние на окислительный и энергетический метаболизм при лечении ожогов у крыс</article-title><trans-title-group xml:lang="en"><trans-title>Pharmaceutical composition of 1,2,4-trioxolanes with betulin in fish oil. Effect on oxidative and energy metabolism in the treatment of burns in rats</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6962-8547</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малыгина</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Malygina</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малыгина Дарина Сергеевна – кандидат фармацевтических наук, доцент кафедры фармацевтической химии и фармакогнозии.</p><p>603005, Нижний Новгород, пл. Минина и Пожарского, 10/1</p></bio><bio xml:lang="en"><p>Darina S. Malygina – Cand. Sc. (Pharm.), Associate Professor at the Department of Pharmaceutical Chemistry and Pharmacognosy, Privolzhsky RMU.</p><p>Minin and Pozharsky square 10/1, Nizhny Novgorod 603005</p></bio><email xlink:type="simple">mds73@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-0443-9527</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ястребов</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yastrebov</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ястребов Павел Викторович – генеральный директор.</p><p>603141, Нижний Новгород, ул. Геологов, 6, пом. П8</p></bio><bio xml:lang="en"><p>Pavel V. Yastrebov – CEO.</p><p>Geologov str. 6, office P8, Nizhny Novgorod 603141</p></bio><email xlink:type="simple">yastrebov@gpnof.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-7150-4599</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фаянс</surname><given-names>А. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Fayans</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фаянс Анна Эдуардовна – первый заместитель генерального директора.</p><p>603141, Нижний Новгород, ул. Геологов, 6, пом. П8</p></bio><bio xml:lang="en"><p>Anna E. Fayans – First Deputy CEO.</p><p>Geologov str. 6, office P8, Nizhny Novgorod 603141</p></bio><email xlink:type="simple">fayans@gpnof.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-9294-0435</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Спицкая</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Spitskaya</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Спицкая Ирина Вячеславовна – кандидат фармацевтических наук, заведующая кафедрой управления и экономики фармации и фармацевтической технологии.</p><p>603005, Нижний Новгород, пл. Минина и Пожарского, 10/1</p></bio><bio xml:lang="en"><p>Irina V. Spitskaya – Cand. Sc. (Pharm.), Head of the Department of Management and Economics of Pharmacy and Pharmaceutical Technology, Privolzhsky RMU.</p><p>Minin and Pozharsky square 10/1, Nizhny Novgorod 603005</p></bio><email xlink:type="simple">iraspitskaya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2680-0562</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Есипович</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Esipovich</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Есипович Антон Львович – кандидат химических наук, заведующий научно-исследовательской лабораторией «Лаборатория биотоплив» (BioFuelLAB), НГТУ им. Р.Е. Алексеева; старший научный сотрудник инженерно-технологического факультета, НГТУ им. Р.Е. Алексеева.</p><p>603022, Нижний Новгород, просп. Гагарина, 23; 603155, Нижний Новгород, ул. Минина, 24</p></bio><bio xml:lang="en"><p>Anton L. Esipovich – Cand. Sc. (Chem.), Head of the Research Laboratory “Laboratory of Biofuels” (BioFuelLAB), NR Lobachevsky SU of Nizhny Novgorod; Senior Research Officer at the Faculty of Engineering and Technology, Nizhny Novgorod STU.</p><p>Gagarina Ave. 23, Nizhny Novgorod 603022Minina str. 24, Nizhny Novgorod 603155</p></bio><email xlink:type="simple">margyn@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6890-4530</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соловьева</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Soloveva</surname><given-names>А. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Соловьева Анна Геннадьевна – доктор биологических наук, старший научный сотрудник Центральной научно-исследовательской лаборатории, ФГБОУ ВО «Приволжский ИМУ» Минздрава России; доцент кафедры биохимии и биотехнологии, НГТУ им. Р.Е. Алексеева.</p><p>603005, Нижний Новгород, пл. Минина и Пожарского, 10/1; 603022, Нижний Новгород, просп. Гагарина, 23</p></bio><bio xml:lang="en"><p>Anna G. Soloveva – Dr. Sc. (Biol.), Senior Research Officer at the Central Research Laboratory, Privolzhsky RMU; Associate Professor at the Department of Biochemistry and Biotechnology, NR Lobachevsky SU of Nizhny Novgorod.</p><p>Minin and Pozharsky square 10/1, Nizhny Novgorod 603005; Gagarina Ave. 23, Nizhny Novgorod 603022</p></bio><email xlink:type="simple">sannag5@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0707-892X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перетягин</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Peretyagin</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перетягин Пётр Владимирович – научный сотрудник Центральной научно-исследовательской лаборатории.</p><p>603005, Нижний Новгород, пл. Минина и Пожарского, 10/1</p></bio><bio xml:lang="en"><p>Petr V. Peretyagin – Research Officer at the Central Research Laboratory.</p><p>Minin and Pozharsky square 10/1, Nizhny Novgorod 603005</p></bio><email xlink:type="simple">peretyaginpv@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1335-1048</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мельникова</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Melnikova</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мельникова Нина Борисовна – доктор химических наук, профессор кафедры аналитической и медицинской химии, ФГАОУ ВО «Нижегородский ГУ им. Н.И. Лобачевского»; ведущий научный сотрудник инженерно-технологического факультета, НГТУ им. Р.Е. Алексеева.</p><p>603022, Нижний Новгород, просп. Гагарина, 23; 603155, Нижний Новгород, ул. Минина, 24</p></bio><bio xml:lang="en"><p>Nina B. Melnikova – Dr. Sc. (Chem.), Professor at the Department of Analytical and Medicinal Chemistry, National Research Lobachevsky State University of Nizhny Novgorod; Leading Research Officer at the Faculty of Engineering and Technology, Nizhny NSTU.</p><p>Minin and Pozharsky square 10/1, Nizhny Novgorod 603005; Gagarina Ave. 23, Nizhny Novgorod 603022</p></bio><email xlink:type="simple">melnikovanb@gmail.com</email><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет» Минздрава России</institution></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГП НО «Нижегородская областная фармация»</institution></aff><aff xml:lang="en"><institution>Pharmacy of the Nizhny Novgorod Region</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Нижегородский государственный университет им. Н.И. Лобачевского»; ФГБОУ ВО «Нижегородский государственный технический университет им. Р.Е. Алексеева»</institution></aff><aff xml:lang="en"><institution>National Research Lobachevsky State University of Nizhny Novgorod; Nizhny Novgorod State Technical University</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет» Минздрава России; ФГАОУ ВО «Нижегородский государственный университет им. Н.И. Лобачевского»</institution></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University; National Research Lobachevsky State University of Nizhny Novgorod</institution></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГАОУ ВО «Нижегородский государственный университет им. Н.И. Лобачевского»; ФГБОУ ВО «Нижегородский государственный технический университет им. Р.Е. Алексеева»</institution></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University; National Research Lobachevsky State University of Nizhny Novgorod</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2024</year></pub-date><volume>9</volume><issue>2</issue><fpage>253</fpage><lpage>263</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малыгина Д.С., Ястребов П.В., Фаянс А.Э., Спицкая И.В., Есипович А.Л., Соловьева А.Г., Перетягин П.В., Мельникова Н.Б., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Малыгина Д.С., Ястребов П.В., Фаянс А.Э., Спицкая И.В., Есипович А.Л., Соловьева А.Г., Перетягин П.В., Мельникова Н.Б.</copyright-holder><copyright-holder xml:lang="en">Malygina D.S., Yastrebov P.V., Fayans A.E., Spitskaya I.V., Esipovich A.L., Soloveva А.G., Peretyagin P.V., Melnikova N.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4747">https://www.actabiomedica.ru/jour/article/view/4747</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Продукты озонирования ненасыщенных жирных кислот в жирах и маслах – 1,2,4-триоксоланы, – способствующие нормализации окислительного и энергетического метаболизма при различных заболеваниях, могут быть перспективной субстанцией для создания новых комбинированных противоожоговых препаратов.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Исследование влияния 1,2,4-триоксоланов в фармацевтической композиции с бетулином, проявляющим ранозаживляющие свойства, на показатели оксидативного стресса и на энергетический метаболизм при лечении ожогов в эксперименте на крысах.</p></sec><sec><title>Методы</title><p>Методы. Эксперименты были проведены на 50 крысах-самцах линии Wistar с ожогом кожи 2-й степени. Оценивали активность ферментов глутатионредуктазы, глюкозо-6-фосфатдегидрогеназы, лактатдегидрогеназы, альдегиддегидрогеназы, супероксиддисмутазы и каталазы, а также уровень показателей перекисного окисления липидов.</p></sec><sec><title>Результаты</title><p>Результаты. Изученысвойства 1,2,4-триоксолановиразработанафармацевтическая композиция 1,2,4-триоксоланов с бетулином из бересты берёзы в рыбьем жире. Исследовано влияние данной композиции на окислительный и энергетический метаболизм у крыс при лечении ожогов. Выявлена активация NADP/H- и NAD/H-зависимых ферментов (глутатионредуктазы, глюкозо6-фосфатдегидрогеназы, лактатдегидрогеназы, альдегиддегидрогеназы), а также супероксиддисмутазы икаталазы, нормализация показателей перекисного окисления липидов под действием изучаемой композиции при лечении ожога. Отмечено влияние композиции на энергетический метаболизм эритроцитов, что было оценено по изменению соотношения активности лактатдегидрогеназы в обратной и прямой реакции. Морфогистологическими исследованиями было показано, что применение композиции в норме и при ожоге не оказывало влияния на структуру стенки желудка, а также улучшало состояние ожоговой раны на 10-й день по сравнению с состоянием раны у животных без лечения.</p></sec><sec><title>Заключение</title><p>Заключение. Предлагаемая композиция 1,2,4-триоксоланов и бетулина в рыбьем жире, позволяющая нормализовать окислительный и энергетический метаболизм и улучшить состояние ожоговой раны без токсического действия на стенки желудка, может быть использована как элемент дополнительной терапии при лечении ожогов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Ozonation products of unsaturated fatty acids in fats and oils – 1,2,4-trioxolanes – which contribute to the normalization of oxidative and energy metabolism in various diseases, may be a promising substance for the creation of new combined anti-burn drugs.</p></sec><sec><title>The aim</title><p>The aim. To study the effect of 1,2,4-trioxolanes in a pharmaceutical composition with betulin, which exhibits wound-healing properties, on indicators of oxidative stress and on energy metabolism in the treatment of burns in an experiment onrats. Methods. The experiments were carried out on 50 male Wistar rats with seconddegree skin burns. We assessed the activity of glutathione reductase, glucose-6-phosphate dehydrogenase, lactate dehydrogenase, aldehyde dehydrogenase, superoxide dismutase and catalase, as well as the level of lipid peroxidation indicators.</p></sec><sec><title>Results</title><p>Results. The properties of 1,2,4-trioxolanes were studied and a pharmaceutical composition of 1,2,4-trioxolanes with betulin from birch bark in fish oil was developed. The effect of this composition on oxidative and energy metabolism in rats during the treatment of burns was studied. The activation of NADP/H and NAD/H dependent enzymes (glutathione reductase, glucose-6-phosphate dehydrogenase, lactate dehydrogenase, aldehyde dehydrogenase), as well as superoxide dismutase and catalase, and the normalization of lipid peroxidation parameters under the influence of the studied composition in the treatment of burns were revealed. The effect of the composition on the energy metabolism of erythrocytes was noted, which was assessed by changes in the ratio of lactate dehydrogenase activity in the reverse and direct reactions. Morphohistological studies showed that using the composition under normal conditions and in case of a burn had no effect on the structure of the stomach wall, and also improved the condition of the burn wound on the day 10 compared to the wound condition in animals without treatment.</p></sec><sec><title>Conclusion</title><p>Conclusion. The proposed composition of 1,2,4-trioxolanes and betulin in fish oil, which allows normalizing oxidative and energy metabolism and improving the condition of a burn wound without toxic effects on the stomach wall, can be used as an element of additional therapy in the treatment of burns.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>активация ферментов антиоксидантной защиты</kwd><kwd>экспериментальное лечение ожогов</kwd><kwd>рыбий жир</kwd><kwd>1</kwd><kwd>2</kwd><kwd>4-триоксолан</kwd><kwd>бетулин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>antioxidant enzymes activation</kwd><kwd>experimental treatment of burns</kwd><kwd>fish oil</kwd><kwd>1</kwd><kwd>2</kwd><kwd>4-trioxolane</kwd><kwd>betulin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Porter C, Tompkins RG, Finnerty CC, Sidossis LS, Suman OE, Herndon DN. The metabolic stress response to burn trauma: Current understanding and therapies. Lancet. 2016; 388(10052): 1417-1426. doi: 10.1016/S0140-6736(16)31469-6</mixed-citation><mixed-citation xml:lang="en">Porter C, Tompkins RG, Finnerty CC, Sidossis LS, Suman OE, Herndon DN. The metabolic stress response to burn trauma: Current understanding and therapies. Lancet. 2016; 388(10052): 1417-1426. doi: 10.1016/S0140-6736(16)31469-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Saraf MK, Herndon DN, Porter C, Toliver-Kinsky T, Radhakrishnan R, Chao T, et al. Morphological changes in subcutaneous white adipose tissue after severe burn injury. J Burn Care Res. 2016; 37(2): 96-103. doi: 10.1097/BCR.0000000000000292</mixed-citation><mixed-citation xml:lang="en">Saraf MK, Herndon DN, Porter C, Toliver-Kinsky T, Radhakrishnan R, Chao T, et al. Morphological changes in subcutaneous white adipose tissue after severe burn injury. J Burn Care Res. 2016; 37(2): 96-103. doi: 10.1097/BCR.0000000000000292</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vassalle C, Maltinti M, Sabatino L. Targeting oxidative stress for disease prevention and therapy: Where do we stand, and where do we go from here. Molecules. 2020; 25(11): 2653. doi: 10.3390/molecules25112653</mixed-citation><mixed-citation xml:lang="en">Vassalle C, Maltinti M, Sabatino L. Targeting oxidative stress for disease prevention and therapy: Where do we stand, and where do we go from here. Molecules. 2020; 25(11): 2653. doi: 10.3390/molecules25112653</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ugazio E, Tullio V, Binello A, Tagliapietra S, Dosio F. Ozonated oils as antimicrobial systems in topical applications. Their characterization, current applications, and advances in improved delivery techniques. Molecules. 2020; 25(2): 334. doi: 10.3390/molecules25020334</mixed-citation><mixed-citation xml:lang="en">Ugazio E, Tullio V, Binello A, Tagliapietra S, Dosio F. Ozonated oils as antimicrobial systems in topical applications. Their characterization, current applications, and advances in improved delivery techniques. Molecules. 2020; 25(2): 334. doi: 10.3390/molecules25020334</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carata E, Tenuzzo BA, Dini L. Powerful properties of ozonated extra virgin olive oil. Herbal Medicine. 2019. doi: 10.5772/intechopen.69412</mixed-citation><mixed-citation xml:lang="en">Carata E, Tenuzzo BA, Dini L. Powerful properties of ozonated extra virgin olive oil. Herbal Medicine. 2019. doi: 10.5772/intechopen.69412</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">De Almeida NR, Beatriz A, de Arruda EJ, de Lima DP, de Oliveira LCS, Micheletti AC. Ozonized vegetable oils: Production, chemical characterization and therapeutic potential. Vegetable Oil: Properties, Uses and Benefits. Nova Science Publishers, Hauppauge; 2016.</mixed-citation><mixed-citation xml:lang="en">De Almeida NR, Beatriz A, de Arruda EJ, de Lima DP, de Oliveira LCS, Micheletti AC. Ozonized vegetable oils: Production, chemical characterization and therapeutic potential. Vegetable Oil: Properties, Uses and Benefits. Nova Science Publishers, Hauppauge; 2016.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Menéndez S, Falcón L, Maqueira Y. Therapeutic efficacy of topical OLEOZON® in patients suffering from onychomycosis. Mycoses. 2011; 54: e272-e277. doi: 10.1111/j.14390507.2010.01898.x</mixed-citation><mixed-citation xml:lang="en">Menéndez S, Falcón L, Maqueira Y. Therapeutic efficacy of topical OLEOZON® in patients suffering from onychomycosis. Mycoses. 2011; 54: e272-e277. doi: 10.1111/j.14390507.2010.01898.x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Valacchi G, Zanardi I, Lim Y, Belmonte G, Miracco C, Sticozzi C, et al. Ozonated oils as functional dermatological matrices: Effects on the wound healing process using SKH1 mice. Int J Pharm. 2013; 458: 65-73. doi: 10.1016/j.ijpharm.2013.09.039</mixed-citation><mixed-citation xml:lang="en">Valacchi G, Zanardi I, Lim Y, Belmonte G, Miracco C, Sticozzi C, et al. Ozonated oils as functional dermatological matrices: Effects on the wound healing process using SKH1 mice. Int J Pharm. 2013; 458: 65-73. doi: 10.1016/j.ijpharm.2013.09.039</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zamora Rodríguez ZB, González Alvarez R, Guanche D, Merino N, Hernández Rosales F, Menéndez Cepero S, et al. Antioxidant mechanism is involved in the gastroprotective effects of ozonized sunflower oil in ethanol-induced ulcers in rats. Mediators Inflamm. 2007; 2007: 65873. doi: 10.1155/2007/65873</mixed-citation><mixed-citation xml:lang="en">Zamora Rodríguez ZB, González Alvarez R, Guanche D, Merino N, Hernández Rosales F, Menéndez Cepero S, et al. Antioxidant mechanism is involved in the gastroprotective effects of ozonized sunflower oil in ethanol-induced ulcers in rats. Mediators Inflamm. 2007; 2007: 65873. doi: 10.1155/2007/65873</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zamora Z, González R, Guanche D, Merino N, Menéndez S, Hernández F, et al. Ozonized sunflower oil reduces oxidative damage induced by indomethacin in rat gastric mucosa. Inflamm Res. 2008; 57(1): 39-43. doi: 10.1007/s00011-007-7034-1</mixed-citation><mixed-citation xml:lang="en">Zamora Z, González R, Guanche D, Merino N, Menéndez S, Hernández F, et al. Ozonized sunflower oil reduces oxidative damage induced by indomethacin in rat gastric mucosa. Inflamm Res. 2008; 57(1): 39-43. doi: 10.1007/s00011-007-7034-1</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Киселевич В.Е., Бессонова Н.Е., Бояринов Г.А., Соколов С.А., Перетягин С.П. Комплекс озонированных ненасыщенных жирных кислот и его применение: Патент № 2725980 Рос. Федерация; МПК A61K 31/19 (2006.01), A61K 35/60 (2006.01), A61P 1/00 (2006.01), A61P 9/00 (2006.01), A61P 11/00 (2006.01). № 2019121013; заявл. 05.07.2019; опубл. 08.07.2020. Бюл. № 19.</mixed-citation><mixed-citation xml:lang="en">Kiselevich VE, Bessonova NE, Boyarinov GA, Sokolov SA, Peretyagin SP. Complex of ozonated unsaturated fatty acids and its application: Patent No. 2725980 of the Russian Federation. 2020; (19). (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Scheffler A. The wound healing properties of betulin from birch bark from bench to bedside. Planta Med. 2019; 85(07): 524-527. doi: 10.1055/a-0850-0224</mixed-citation><mixed-citation xml:lang="en">Scheffler A. The wound healing properties of betulin from birch bark from bench to bedside. Planta Med. 2019; 85(07): 524-527. doi: 10.1055/a-0850-0224</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Manzhulo IV, Tyrtyshnaia AA, Manzhulo OS, Starinets AA, Kasyanov SP, Dyuizen IV. Neuroprotective activity of docosahexaenoic acid in the central and peripheral nervous system after damage to the sciatic nerve. Neurochem J. 2020; 14(1): 101-107. doi: 10.1134/S1819712420010158</mixed-citation><mixed-citation xml:lang="en">Manzhulo IV, Tyrtyshnaia AA, Manzhulo OS, Starinets AA, Kasyanov SP, Dyuizen IV. Neuroprotective activity of docosahexaenoic acid in the central and peripheral nervous system after damage to the sciatic nerve. Neurochem J. 2020; 14(1): 101-107. doi: 10.1134/S1819712420010158</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ghasemi Fard S, Wang F, Sinclair AJ, Elliott G, Turchini GM. How does high DHA fish oil affect health? A systematic review of evidence. Crit Rev Food Sci Nutr. 2019; 59(11): 1684-1727. doi: 10.1080/10408398.2018.1425978</mixed-citation><mixed-citation xml:lang="en">Ghasemi Fard S, Wang F, Sinclair AJ, Elliott G, Turchini GM. How does high DHA fish oil affect health? A systematic review of evidence. Crit Rev Food Sci Nutr. 2019; 59(11): 1684-1727. doi: 10.1080/10408398.2018.1425978</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sega A, Zanardi I, Chiasserini L, Gabbrielli A, Bocci V, Travagli V. Properties of sesame oil by detailed 1H and 13C NMR assignments before and after ozonation and their correlation with iodine value, peroxide value, and viscosity measurements. Chem Phys Lipids. 2010; 163(2): 148-156. doi: 10.1016/j.chemphyslip.2009.10.010</mixed-citation><mixed-citation xml:lang="en">Sega A, Zanardi I, Chiasserini L, Gabbrielli A, Bocci V, Travagli V. Properties of sesame oil by detailed 1H and 13C NMR assignments before and after ozonation and their correlation with iodine value, peroxide value, and viscosity measurements. Chem Phys Lipids. 2010; 163(2): 148-156. doi: 10.1016/j.chemphyslip.2009.10.010</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zanardi I, Travagli V, Gabbrielli A, Chiasserini L, Bocci V. Physico-chemical characterization of sesame oil derivatives. Lipids. 2008; 43(9): 877-886. doi: 10.1007/s11745-008-3218-x</mixed-citation><mixed-citation xml:lang="en">Zanardi I, Travagli V, Gabbrielli A, Chiasserini L, Bocci V. Physico-chemical characterization of sesame oil derivatives. Lipids. 2008; 43(9): 877-886. doi: 10.1007/s11745-008-3218-x</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ; 2-е изд., перераб. и доп. М.: Медицина; 2005.</mixed-citation><mixed-citation xml:lang="en">Khabriev RU. Guidelines for the experimental (preclinical) study of new pharmacological substances; 2nd edition, revised and enlarged. Moscow: Meditsina; 2005. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Лампатов В.В., Семенихина Н.М., Халимов Р.И. Способ моделирования термического поражения кожи степени IIIA: Пат. № 2712051 Рос. Федерация; МПК G09B 23/28 (2006.01), A61B 18/04 (2006.01). № 2019100831; заявл. 10.01.2019; опубл. 24.01.2020. Бюл. № 3.</mixed-citation><mixed-citation xml:lang="en">Lampatov VV, Semenikhina NM, Khalimov RI. Method for simulating thermal skin damage of IIIA degree: Patent No. 2712051 of the Russian Federation. 2020; (3). (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Перетягин П.В., Соловьева А.Г., Лузан А.С., Воробьев Е.В., Диденко Н.В. Устройство для экспериментального моделирования термической травмы кожи: Описание полезной модели к Патенту № 179126 Рос. Федерация; МПК A61B 18/04 (2006.01), G09B 23/28 (2006.01). № 2017123921; заявл. 05.07.2017; опубл. 26.04.2018. Бюл. № 12.</mixed-citation><mixed-citation xml:lang="en">Peretyagin PV, Solovieva AG, Luzan AS, Vorobyov EV, Didenko NV. Device for experimental modeling of thermal skin injury: Description of the utility model for the Patent No. 179126 of the Russian Federation. 2018; (12). (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Martusevich AK, Larionova KD, Peretyagin SP, Peretyagin PV, Davyduk AV. Experimental estimation of pharmacological compositions effect on microcirculation state at early postburn period. Fundam Res. 2013; 3: 332-336.</mixed-citation><mixed-citation xml:lang="en">Martusevich AK, Larionova KD, Peretyagin SP, Peretyagin PV, Davyduk AV. Experimental estimation of pharmacological compositions effect on microcirculation state at early postburn period. Fundam Res. 2013; 3: 332-336.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Dahmus JD, Bruning RS, Kenney WL, Alexander LM. Oral clopidogrel improves cutaneuos microvascular function through EDHF-dependent mechanisms in middle-aged humans. Am J Physiol Regul Integr Comp Physiol. 2013; 305: R452-R458. doi: 10.1152/ajpregu.00366.2012</mixed-citation><mixed-citation xml:lang="en">Dahmus JD, Bruning RS, Kenney WL, Alexander LM. Oral clopidogrel improves cutaneuos microvascular function through EDHF-dependent mechanisms in middle-aged humans. Am J Physiol Regul Integr Comp Physiol. 2013; 305: R452-R458. doi: 10.1152/ajpregu.00366.2012</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017; 86: 715-748. doi: 10.1146/annurev-biochem-061516-045037</mixed-citation><mixed-citation xml:lang="en">Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017; 86: 715-748. doi: 10.1146/annurev-biochem-061516-045037</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Seyam O, Smith NL, Reid I, Gandhi J, Jiang W, Khan SA. Clinical utility of ozone therapy for musculoskeletal disorders. Med Gas Res. 2018; 8(3): 103-110. doi: 10.4103/2045-9912.241075</mixed-citation><mixed-citation xml:lang="en">Seyam O, Smith NL, Reid I, Gandhi J, Jiang W, Khan SA. Clinical utility of ozone therapy for musculoskeletal disorders. Med Gas Res. 2018; 8(3): 103-110. doi: 10.4103/2045-9912.241075</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Re L, Mawsouf MN, Menendez S, Leon OS, Sanchez GM, Hernandez F. Ozone therapy: Clinical and basic evidence of its ther-apeutic potential. Arch Med Res. 2008; 39: 17-26. doi: 10.1016/j.arcmed.2007.07.005</mixed-citation><mixed-citation xml:lang="en">Re L, Mawsouf MN, Menendez S, Leon OS, Sanchez GM, Hernandez F. Ozone therapy: Clinical and basic evidence of its ther-apeutic potential. Arch Med Res. 2008; 39: 17-26. doi: 10.1016/j.arcmed.2007.07.005</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mori TA, Burke V, Puddey IB, Watts GF, O’Neal DN, Best JD, et al. Purified eicosapentaenoic and docosahex-aenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hy-perlipidemic men. Am J Clin Nutr. 2000; 71(5): 1085-1094. doi: 10.1093/ajcn/71.5.1085</mixed-citation><mixed-citation xml:lang="en">Mori TA, Burke V, Puddey IB, Watts GF, O’Neal DN, Best JD, et al. Purified eicosapentaenoic and docosahex-aenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hy-perlipidemic men. Am J Clin Nutr. 2000; 71(5): 1085-1094. doi: 10.1093/ajcn/71.5.1085</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care. 2007; 10: 136-141. doi: 10.1097/MCO.0b013e32802b7030</mixed-citation><mixed-citation xml:lang="en">Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care. 2007; 10: 136-141. doi: 10.1097/MCO.0b013e32802b7030</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamoto K, Nishinaka T, Mankura M, Fujita-Hamabe W, Tokuyama S. Antinociceptive effects of docosahexaenoic acid against various pain stimuli in mice. Biol Pharm Bull. 2010; 33: 1070-1072. doi: 10.1248/bpb.33.1070</mixed-citation><mixed-citation xml:lang="en">Nakamoto K, Nishinaka T, Mankura M, Fujita-Hamabe W, Tokuyama S. Antinociceptive effects of docosahexaenoic acid against various pain stimuli in mice. Biol Pharm Bull. 2010; 33: 1070-1072. doi: 10.1248/bpb.33.1070</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
